Clinical Trial Update: Multiple Ascending Dose Study of PRX002 in Patients With Parkinson's Disease [Phase 1]

View source ↗

Summary

Phase 1 multiple ascending dose study of PRX002 in Parkinson's disease has completed, as reported in the clinical trial update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• PRX002

Snippet

Sponsor: Prothena Biosciences Limited | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED